Broadcasting News

Lee Mi-sook: “I’m afraid my daughter-in-law might come to visit… I’ll send her on a trip even during the holidays”

Lee Mi-sook Makes Dumplings for Chuseok "Family Arguments Are Common During the Holidays"

Gim Ga Yeong
2026-09-19 17:23:08
[Edaily Starin Gim Ga Yeong Reporter] Actress Lee Mi-sook demonstrated an open-minded attitude.
A recent video on the YouTube channel “Lee Mi-sook: Ms. Mi-sook with a Touch of Class” featured Lee Mi-sook making dumplings in preparation for the holiday season.
While making dumplings, Lee Mi-sook confessed, “I wouldn’t make my daughter-in-law do something like this,” adding, “I’m scared she might come over.”
She continued, “I wouldn’t even call her during the holidays; I’d tell her to go on a trip,” explaining, “I’m busy during the holidays.”
She also mentioned situations where arguments break out during family gatherings on holidays. She nagged her friends as they made dumplings, saying, “This is nagging time disguised as dumpling-making,” and added, “That’s just how it is. Isn’t that why people say there are so many fights during Chuseok and other holidays?”
Meanwhile, Lee Mi-sook has launched the YouTube channel “Lee Mi-sook: Ms. Mi-sook, the Down-to-Earth One” and is gaining popularity by sharing glimpses of her unpretentious daily life.

Economy

Corporation

IT·Science

Economy

[VC's Pick] The AI That Played a Match Against Lee Sedol 9-dan… Enhance Secures 51.2 Billion Investment

This week (September 14–18), startups in various fields—including medical artificial intelligence (AI), content solutions, and content tech—secured investments from venture capital (VC) firms and acce…
2026-09-19 09:21:04

Corporation

Kang Seong-min, CEO of PeopleBio, Inc.: “Full-Scale Launch of LDT and Diagnostic Kit Business in the U.S. … Revenue to Become Apparent Starting Next Year”

“Building on our designation as an innovative medical device by the U.S. Food and Drug Administration (FDA), we plan to establish a local subsidiary within this year. Next year, we will launch laborat…
2026-09-19 08:07:02

IT·Science

Opacalim Clinical Trials Paused… A Closer Look at the Preconditions for SK BIOPHARMACEUTICALS’s 2.3 Trillion Won Deal

SK BIOPHARMACEUTICALS(326030)has drawn attention by repeatedly emphasizing that the deal to acquire “Opacalym” (BHV-7000), a new drug candidate for epilepsy, from the U.S. biotech company Biohaven is …
2026-09-19 08:41:01